Harrow To Report Second Quarter 2026 Financial Results After Market Close on August 10, 2026
Harrow updates financial calendar with upcoming quarterly results release and investor call
Can New Retina Data Deepen Harrow’s (HROW) Moat In Ophthalmology Or Just Refine Its Story?
Harrow says QUELL trial of IHEEZO posts topline data in Q4 2026
How Investors May Respond To Harrow (HROW) Taking Over BYOOVIZ US Commercialization And Ophthalmic Biosimilars
Harrow (NASDAQ:HROW) Trading Down 4.8% - What's Next?